A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2+ breast cancer

by Costa R, Zaman S, Sharpe S, Helenowski I, Shaw C, Han H, Soliman H, Czerniecki B
Published 2019-01-01